Pedro Fonte | Nanomedicine | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Pedro Fonte | Nanomedicine | Best Researcher Award

Assist. Prof. Dr. Pedro Fonte, Faculty of Sciences and Technology, University of Algarve, Portugal

Assist. Prof. Dr. Pedro Fonte is a distinguished researcher in pharmaceutical technology and nanomedicine. He earned his PhD in Pharmaceutical Sciences – Nanotechnologies from the University of Porto and the University of Copenhagen in 2016, supported by an FCT scholarship. He is currently an Assistant Professor at the University of Algarve and leads the Biomaterials and Nanomedicine Lab at CCMAR and iBB, IST–ULisboa. With over 63 peer-reviewed publications, 11 book chapters, and an h-index of 31, he has been recognized among the Top 2% Scientists globally by Stanford University/Elsevier since 2021. His research focuses on nanocarrier-based drug delivery systems, having mentored numerous PhD and postdoctoral researchers. He previously held academic and leadership positions at Lusófona University and has contributed to international scientific bodies, including COST and the Science Fund of Serbia. Dr. Fonte is also an editor and author of several scientific books and experimental protocols in his field.

Publication Profile

Scopus

Orcid

Academic Background

Assist. Prof. Dr. Pedro Fonte has a strong multidisciplinary academic background, integrating pharmaceutical sciences, nanotechnology, and business management. He earned his PhD in Pharmaceutical Sciences – Nanotechnologies in 2016 from the Faculty of Pharmacy, University of Porto (Portugal), and the Faculty of Health and Medical Sciences, University of Copenhagen (Denmark), under the supervision of Drs. Bruno Sarmento, Salette Reis, and Marco van de Weert. His thesis, titled “Optimization of lyophilization parameters of polymeric nanoparticles for delivery of therapeutic proteins,” was completed with distinction and supported by an FCT scholarship (SFRH/BD/78127/2011). In 2012, he obtained an MBA in Business Management and Administration from Lusíada University, Porto, with a classification of 15 values. Prior to this, he completed an Integrated Master in Pharmaceutical Sciences in 2010 and a Bachelor’s degree in the same field in 2009 at the Advanced Institute of Health Sciences – North, CESPU, Gandra-Prd, Portugal, with classifications of 15 and 14 values, respectively.

Professional Journey

Assist. Prof. Dr. Pedro Fonte has established a distinguished academic and research career in biomaterials and nanomedicine. Since October 2019, he has served as Assistant Professor at the University of Algarve and Group Leader at Fonte’s Lab, affiliated with CCMAR and iBB, both recognized research units in Portugal. He is also an integrated member of CCMAR and a collaborating researcher at iBB. Previously, Dr. Fonte held positions at Lusófona University, including Assistant Professor, Director of the Biomedical Nanoscience Lab, and Group Leader in Biomaterials. He was also affiliated with LAQV/REQUIMTE and UCIBIO/REQUIMTE, both classified as excellent R&D units. His doctoral studies spanned institutions like the University of Porto, University of Copenhagen, and University of Lisbon, supported by FCT grants. Earlier in his career, he undertook multiple internships and fellowships in hospital, community pharmacy, and clinical labs, laying the groundwork for his pioneering work in nanomedicine and drug delivery.

Teaching and Pedagogical Contributions

Prof. Pedro Fonte has made remarkable contributions to academic development through the creation and dissemination of high-quality pedagogical materials in pharmaceutical technology and nanomedicine. His scholarly dedication is evident in the authorship of 11 textbook publications and 4 detailed experimental protocols, which serve as valuable resources for students and researchers alike. He has also contributed 7 encyclopaedia entries and 4 insightful articles to magazines and newsletters, enhancing public and academic understanding of complex scientific topics. Embracing modern educational tools, Prof. Fonte has developed 5 computer applications and 3 experimental prototypes that support interactive learning and research. Furthermore, he has produced a wide array of teaching materials tailored to various educational levels and contexts. His pedagogical work reflects a deep commitment to fostering learning through innovative and accessible content, positioning him as a key academic figure in advancing education in pharmaceutical sciences and nanomedicine across national and international platforms.

Research Focus

Prof. Pedro Fonte’s research is centered on advanced drug delivery systems, with a particular emphasis on nanotechnology, biomaterials, and biopharmaceuticals. His work spans a diverse range of applications, including wound healing, cancer therapy, tuberculosis treatment, and oral and inhalable delivery of therapeutic proteins and peptides. He has made substantial contributions to the development of nanoparticle-based systems, such as PLGA nanoparticles, mesoporous silica carriers, and lipid-based nanostructures, aimed at enhancing the stability, targeting, and bioavailability of drugs. His recent publications highlight innovations in freeze-drying of biopharmaceuticals, mucoadhesive systems, and nanonutraceuticals. Prof. Fonte also explores the biomedical application of sustainable materials like carbon dots in imaging and treatment, demonstrating a strong commitment to translational research. His multidisciplinary collaborations and editorial contributions to high-impact journals and books further emphasize his leading role in pharmaceutical nanotechnology and the development of next-generation therapeutics for chronic and infectious diseases

Publication Top Notes

  • Delivery of therapeutic proteins for wound healing (book chapter, 2024) –ScienceDirect+9OUCI+9cienciavitae.pt+9

  • Drug delivery systems for mouth wound healing (book chapter, 2024) – cienciavitae.pt+1ResearchGate+1

  • Unravelling the drying techniques of protein biopharmaceuticals (book chapter, 2024) –cienciavitae.pt+1ResearchGate+1

  • Inhalable N‑Acetylcysteine‑loaded Lactose‑coated PLGA Nanoparticles for Tuberculosis Treatment (Journal article, 2025) 

  • Impact of chain‑length of sulfhydryl‑modified surface‑decorated surfactants on mucoadhesive nanostructured lipid carriers (Journal article, 2025)

  • Recent advances in antibacterial nanoformulations for endodontic applications (Journal article, 2025) 

  • Camptothecin‑loaded mesoporous silica nanoparticles… skin cancer treatment (Journal article, 2024) 

  • Transforming cancer treatment: The potential of nanonutraceuticals (Journal article, 2024) 

 

 

Sémah Tagougui | Exercise | Best Researcher Award

Published on by Global Academic Awards

Dr. Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui at University of Lille, France

Dr. Sémah Tagougui is a University Lecturer at the University of Lille  and an internationally recognized researcher in exercise physiology, type 1 diabetes, and metabolic health 🧠. With a Ph.D. in Life Sciences and postdoctoral training in Brussels and Montreal , he leads innovative projects on glycemic control, including AI-based tools  and insulin technologies. He has secured competitive grants , published high-impact research 📚, and regularly speaks at global conferences. Honored with the RIPEC Award for Scientific Excellence 🏅, Dr. Tagougui’s work bridges clinical science and real-world application for chronic disease management 🩺.

Publication Profile

Orcid

Scopus

Google Scholar

Academic Background

Dr. Sémah Tagougui holds a Ph.D. in Life Sciences from the University of Lille , where his research focused on muscle and cerebral oxygenation in individuals with type 1 diabetes 💉. He also earned a Master’s degree in Adapted Physical Activities and Health from the same university 🏃‍♂️🩺. He completed two prestigious postdoctoral fellowships—one in Brussels  and another at the Institute of Clinical Research in Montreal . In 2022, he received his Habilitation to Supervise Research, a mark of academic excellence 🏅. His educational path reflects a strong commitment to clinical and physiological research 📚.

Professional Experience

Dr. Sémah Tagougui is currently serving as a University Lecturer at the University of Lille , where he has been actively teaching and conducting research since 2019 📚. He previously held roles as an ATER and doctoral tutor at the same university, shaping future professionals in sports science and health 🧠. His international experience includes postdoctoral research positions in Brussels  and Montreal , focusing on diabetes, exercise physiology, and metabolic health 💉. Dr. Tagougui also plays key roles in international collaborative projects , thesis committees , and scientific advisory panels, demonstrating leadership in academic and clinical research 🔬🩺.

Awards and Honors

Dr. Sémah Tagougui has received several prestigious awards in recognition of his outstanding contributions to science and health research 💉. In 2023, he was honored with the RIPEC Award for Scientific Excellence by the French National Council of Universities 🎖️. He also secured multiple competitive grants, including the Young Francophone Researcher Grant and the FRM Research Hope Grant 📑. His invited speaker roles at renowned institutions and conferences 🌍 further highlight his influence in the field. These accolades reflect his dedication to advancing knowledge in type 1 diabetes, exercise science, and metabolic health 🔬.

Research Focus

Dr. Sémah Tagougui’s research centers on the intersection of type 1 diabetes, exercise physiology, and metabolic health 💉. His work explores how physical activity impacts glycemic control, muscle oxygenation, and cerebral function in individuals with diabetes . He is actively developing AI-powered tools for personalized blood glucose prediction  and has contributed to cutting-edge studies on insulin technologies, artificial pancreas systems, and exercise-induced glucose fluctuations 🧬. Collaborating internationally , his goal is to transform exercise from a risk factor into a therapeutic strategy for diabetes management 🌍. His research has real-world clinical impact and global relevance 🌐📚.

Publication Top Notes

Acute cocoa flavanol improves cerebral oxygenation without enhancing executive function at rest or after exercise
📅 Year: 2016 | 🔢 Cited by: 68

The benefits and limits of technological advances in glucose management around physical activity in patients with type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 62

Muscle oxygen supply impairment during exercise in poorly controlled type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 62

Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives
📅 Year: 2019 | 🔢 Cited by: 52

Aerobic fitness influences cerebral oxygenation response to maximal exercise in healthy subjects
📅 Year: 2015 | 🔢 Cited by: 38

A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes
📅 Year: 2020 | 🔢 Cited by: 35

Muscle oxygen supply and use in type 1 diabetes: is there a limiting step?
📅 Year: 2020 | 🔢 Cited by: 33

Barriers to physical activity in children and adults living with type 1 diabetes: a complex link with real-life glycemic excursions
📅 Year: 2023 | 🔢 Cited by: 31

Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum during moderate intensity exercise in type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 27

Regional cerebral hemodynamic response to incremental exercise is blunted in poorly controlled patients with uncomplicated type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 22

Minimizing risk of exercise-induced glucose fluctuations in type 1 diabetes using insulin infusion: overview of strategies
📅 Year: 2021 | 🔢 Cited by: 19

Effectiveness of Ramadan fasting and concurrent training in obesity management: is the combination worth the weight?
📅 Year: 2023 | 🔢 Cited by: 18

Conclusion

Dr. Sémah Tagougui is an outstanding candidate for the Best Researcher Award due to his exemplary academic background, including a distinguished Ph.D. and postdoctoral fellowships, along with his habilitation to supervise research, demonstrating senior scientific leadership. As a University Lecturer at the University of Lille, he has led numerous competitive international grants and acted as Principal Investigator on innovative projects bridging exercise physiology and diabetes management. His high-impact publications in top journals and extensive citations reflect significant contributions to the field. Dr. Tagougui’s strong international collaborations, invited speaker roles, and translational focus on improving clinical outcomes highlight his sustained excellence, making him highly deserving of this honor.

 

 

Serpil Demir-Tuna | Physical Medicine | Women Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Serpil Demir-Tuna | Physical Medicine | Women Researcher Award

Assoc. Prof. Dr. Serpil Demir-Tuna, Akdeniz University Faculty of Medicine, Turkey

Assoc. Prof. Dr. Serpil Demir-Tuna is a distinguished physician specializing in Physical Medicine and Rehabilitation at Akdeniz University School of Medicine, Antalya, Turkey. With a career spanning over two decades, she has made significant contributions to aging, sarcopenia, musculoskeletal ultrasound, and osteoarthritis. Dr. Demir-Tuna has published extensively in top-tier medical journals, exploring the intersections of muscle health, joint disorders, and AI-driven solutions in healthcare. Her expertise extends to rheumatologic conditions, neuropathic pain, and metabolic syndrome in arthritis patients. She has been actively involved in clinical research, contributing valuable insights into the diagnosis and treatment of musculoskeletal disorders. A dedicated educator, she mentors young medical professionals while continuing her research on rehabilitation strategies for aging populations. Dr. Demir-Tuna’s work is widely recognized, earning her numerous accolades in the medical community. 📚🏆

Publication Profile

Orcid

Education 🎓

Dr. Serpil Demir-Tuna pursued her medical education at Ege University School of Medicine, graduating in 1999. She further specialized in Physical Medicine and Rehabilitation at Akdeniz University Medical School, where she completed her residency in 2005. Her academic training provided a strong foundation in musculoskeletal medicine, rehabilitation techniques, and pain management strategies. Throughout her education, she gained extensive clinical experience in diagnosing and treating neuromuscular and joint disorders, with a particular focus on sarcopenia, osteoarthritis, and musculoskeletal ultrasound applications. She actively participated in research programs, contributing to advancements in age-related muscle loss and innovative rehabilitation approaches. Her commitment to continuous learning has led her to attend numerous specialized training programs and workshops in AI applications in medicine, rheumatology, and pain management. This rigorous academic background has shaped her into an expert in the field of rehabilitation and aging-related musculoskeletal conditions. 📖🔬

Experience 💼

Dr. Serpil Demir-Tuna has been a dedicated physician, researcher, and educator at Akdeniz University Medical School, Department of Physical Medicine and Rehabilitation since 2005. With a strong focus on musculoskeletal health and aging, she has led numerous clinical trials and research projects exploring sarcopenia, osteoarthritis, and the role of musculoskeletal ultrasound in diagnostics. She has been instrumental in training medical students, residents, and fellows in the latest rehabilitation techniques. Over the years, she has developed innovative rehabilitation protocols for patients with chronic musculoskeletal conditions, neuropathic pain, and metabolic disorders. In addition to her academic responsibilities, she has served as a reviewer for international medical journals, evaluating research on rehabilitation strategies and musculoskeletal health. Her expertise in AI-driven healthcare solutions and commitment to evidence-based medicine have positioned her as a leader in the field of rehabilitation medicine and aging research. 🏥📊

Awards & Honors 🏅

Dr. Serpil Demir-Tuna has received multiple awards for her outstanding contributions to Physical Medicine and Rehabilitation. Her research on sarcopenia and osteoarthritis has been recognized with prestigious research grants and best paper awards at international conferences. She has been honored by medical societies and academic institutions for her groundbreaking work on muscle health, joint disorders, and AI-driven solutions in rehabilitation. Her role as a distinguished educator has earned her teaching excellence awards, highlighting her impact on medical education and mentorship. She has also been recognized for her collaborative research efforts in rheumatology and musculoskeletal disorders, receiving accolades for her work on metabolic syndrome in arthritis patients. As a thought leader in rehabilitation medicine, she has been invited as a keynote speaker at global medical symposia, further solidifying her reputation as a pioneer in musculoskeletal research. 🏆📚

Research Focus 🔬

Dr. Serpil Demir-Tuna’s research primarily focuses on aging-related musculoskeletal conditions, with an emphasis on sarcopenia, osteoarthritis, and musculoskeletal ultrasound. She investigates the pathophysiology of muscle loss in aging populations and explores novel rehabilitation strategies to improve muscle function and mobility. Her work also delves into the relationship between cartilage health and metabolic disorders, uncovering links between femoral cartilage thickness and knee osteoarthritis. She has contributed significantly to neuropathic pain research, identifying its prevalence in osteoarthritis patients. Additionally, she has explored the role of AI-driven healthcare solutions in managing sarcopenia and nutrition-related disorders. Her studies on inflammatory markers and autoimmune diseases provide insights into conditions like Behçet’s disease and Sjögren’s syndrome. Through her multidisciplinary research approach, she continues to shape the future of rehabilitation medicine with innovative diagnostic and treatment methodologies. 🏥🧬

Publication Top Notes

  • 🦵 Relationship Between Sarcopenia, Femoral Cartilage Thickness, and Knee Osteoarthritis: Case–Control Study | International Journal of Rheumatic Diseases | 2025 | DOI: 10.1111/1756-185X.70179

  • 🩸 Neuropathic Pain in Knee Osteoarthritis: Prevalence, Diagnosis, and Clinical Implications | Joint Diseases and Related Surgery | 2025 | DOI: 10.52312/jdrs.2025.1979

  • 💤 Is There an Association Between Restless Legs Syndrome and Urticaria? | Journal of Korean Medical Science | 2016 | DOI: 10.3346/jkms.2016.31.5.790

Conclusion

Assoc. Prof. Dr. Serpil Demir-Tuna’s dedication to research, academic leadership, and clinical expertise makes her a strong candidate for the Women Researcher Award. Her innovative contributions in the field of Physical Medicine and Rehabilitation exemplify the award’s purpose of recognizing excellence in research.

Jiaqi Lou | Clinical medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou, Ningbo No.2 Hospital, China

Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Master’s degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospital’s Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.

Publication Profile

Scopus

Orcid

Education 🎓📚

Lou Jiaqi pursued his Bachelor’s degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Master’s degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.

Experience 🏥

Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospital’s Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.

Awards & Honors 🏆🎖️

Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.

Research Focus 🔬🧬

Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.

 

Publication Top Notes

  • “A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.

    ACM Digital Library

  • “Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.

    ACM Digital Library

  • “The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.

    ACM Digital Library

  • “A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.

    ACM Digital Library

  • “A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.

    ACM Digital Library

  • “Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.

    ACM Digital Library

  • “Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.

    ACM Digital Library

  • “Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.

    ACM Digital Library

  • “Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.

    ACM Digital Library

  • “PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.

    ACM Digital Library

 

 

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Dr Mohammadamin Parsaei, Maternal, Fetal & Neonatal Research Center, Iran

Dr. Mohammadamin Parsaei is a prominent academic and researcher specializing in [specific field]. He holds a [degree] from [institution] and has extensive experience in [area of expertise]. Dr. Parsaei is known for his contributions to [specific research focus or project], with numerous publications and impactful research outcomes. He is currently affiliated with [institution] as a [position], where he continues to advance knowledge in [field]. His work is widely recognized for its innovation and excellence. 📚🔬

Publication profile

google scholar

Education

Dr. Mohammadamin Parsaei earned their Doctor of Medicine degree from Tehran University of Medical Sciences in 2023, with a GPA of 3.68/4. Their thesis, titled “Assessing Clinical Outcomes of Adrenalectomy and Associated Factors: A Retrospective Study in Iran,” was successfully defended before the General Surgery faculty at Dr. Shariati Hospital, Tehran University of Medical Sciences. This research delves into the clinical outcomes of adrenalectomy procedures and explores the associated factors affecting patient outcomes in Iran. 🏥📚👩‍⚕️

Experience

Dr. Mohammadamin Parsaei is a Postdoctoral Research Fellow at the Maternal, Fetal & Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences (2023-present). In this role, Dr. Mohammadamin Parsaei conducts clinical trials, observational studies, and reviews in Obstetrics and Gynecology, Infertility, and Maternal-Fetal research. Responsibilities include statistical analysis, overseeing research projects, crafting proposals, and managing article submissions. Additionally, Dr. [Name] serves as a Research Supervisor at ResearchPlus Academy (2024-present) and NCWEB Association (2023-present), leading systematic reviews and meta-analyses in multidisciplinary fields and neuroradiology. 🧪📊🔬

Research focus

The research of M. Parsaei predominantly focuses on psychiatric and psychological disorders, neuroimaging, and reproductive health. Key areas include the efficacy and safety of psychiatric medications, the impact of neuroimaging on mental health conditions like schizophrenia and social anxiety disorders, and the role of various interventions in managing these conditions. Parsaei’s work also extends to evaluating treatments for reproductive health issues, such as ectopic pregnancies, and the effects of maternal obesity on offspring brain development. This diverse research contributes to understanding and improving mental health, neuroimaging techniques, and reproductive outcomes. 🧠🔬💊👶

Publication top notes

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

Classification of suicidality by training supervised machine learning models with brain MRI findings: A systematic review

White matter alterations in affective and non-affective early psychosis: A diffusion MRI study

Methotrexate as the first-line treatment of unruptured tubular ectopic pregnancies with high initial human chorionic gonadotropin levels: A retrospective cohort

Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review

Microstructural white matter alterations associated with social anxiety disorders: A systematic review

Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial

Machine Learning for Prediction of Violent Behaviors in Schizophrenia Spectrum Disorders: A Systematic Review

White matter correlates of impulsive behavior in healthy individuals: A diffusion MRI study

Predicting the Outcomes of In Vitro Fertilization Using Baseline Maternal Serum Inflammatory Markers: A Retrospective Cohort Study

Erica Pietroluongo | Medicine | Young Scientist Award

Published on by Global Academic Awards

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes:

Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer

Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors